Ketamina Molteni (Ketamine Hydrochloride)

Ketamine works by blocking NMDA receptors in the central nervous system, which reduces excitatory neurotransmission. This action leads to dissociation, analgesia, and loss of consciousness, while also influencing opioid receptors and monoamine pathways to support its anesthetic profile.

The dose of ketamine is determined by the prescribing clinician based on the specific procedure, patient characteristics, and route of administration. Dosing is individualized and should follow established medical guidelines and institutional protocols.

Safety data for ketamine during pregnancy and lactation are limited. It is generally classified as a category C medication, meaning it should only be used if the potential benefits justify the potential risks to the fetus or infant. Consultation with a specialist is recommended.

To order Ketamina Molteni, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Ketamine is distinct from many inhalational or opioid anesthetics because it provides both analgesia and dissociative anesthesia without causing significant respiratory depression. Its sympathomimetic effects can maintain blood pressure, making it useful in trauma, but it may produce psychomimetic side effects not seen with other agents.

Ketamina Molteni should be stored at controlled room temperature, protected from light and moisture, and kept in its original container. Avoid freezing or exposing the product to extreme temperatures, and handle it using aseptic techniques to maintain sterility.

Ketamina Molteni is administered by a qualified healthcare professional via intramuscular or intravenous injection. The route, rate of injection, and total dose are selected based on the clinical indication and patient response, following standard anesthesia practice.

Serious risks associated with ketamine include respiratory depression, severe hypertension or arrhythmias, emergence reactions such as agitation or psychosis, and increased intracranial pressure. Continuous monitoring of airway, breathing, and cardiovascular status is essential during and after administration.

Ketamine is contraindicated in patients with uncontrolled hypertension, severe coronary artery disease, elevated intracranial pressure, known hypersensitivity to ketamine, or those taking monoamine oxidase inhibitors. Caution is also advised for individuals with a history of psychosis or severe psychiatric disorders.